HHS/FDA Announcement Bolsters Else Nutrition's Momentum in Bringing its Infant Formula to Market in the United States
VANCOUVER, BC, March 20, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"),applauds the leadership of Secretary Robert F. Kennedy in launching Operation Stork Speed, a strategic initiative by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) aimed at expanding infant formula options. This effort demonstrates the importance of nutritional adequacy and supply chain resilience while facilitating the development of new infant formulas within the United States.
Else Logo (CNW Group/Else Nutrition Holdings Inc.)
As part of its commitment to bringing the first whole food, minimally processed, clean-label, plant-based infant formula to American families, Else Nutrition has been actively engaged in a robust Washington D.C. effort through its U.S. office. This includes hiring a leading healthcare lobbying firm, conducting bipartisan Congressional meetings across both chambers, and preparing to launch a grassroots lobbying program. To date, this effort has resulted in significant Congressional oversight on modernized FDA guidance on plant-based, non-soy, non-dairy infant formula options—an essential step for Else Nutrition to conduct key clinical trials in the U.S.
In January 2025, the FDA released their Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, which followed the National Academies of Sciences, Engineering, and Medicine also recently convening a study on these issues. This week's announcement of Operation Stork Speed is another significant step from HHS in ensuring access to safe, high quality infant formulas.
"At Else Nutrition, we are dedicated to ensuring that families across America have access to safe, high-quality, minimally processed plant-based nutrition options," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "Many infants with medical, dietary or dietary needs require such formulas. Congress has taken significant action to ensure access to these formulas and we are pleased to see the Administration continue this most important work. We applaud President Trump and Secretary Robert F. Kennedy for their leadership in launching Operation Stork Speed and look forward to collaborating with HHS and the FDA to create a modernized regulatory pathway for plant-based, non-soy, non-dairy infant formulas. By combining rigorous science with the power of natural ingredients like almonds, buckwheat, and tapioca, we are redefining early childhood nutrition to be healthier, more sustainable, and more accessible to parents seeking clean-label alternatives."
About Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
"2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
"Best Dairy Alternative" Award 2021 at World Plant-Based Expo
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named Among the Best in Family-Friendly Products by the Prestigious Mom's Choice Awards®
TSX Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
